2019 annual financial data
Silence Therapeutics 2019 Operating margin
Silence Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -9,317.21%.
Operating income was -22,734,000 GBP and net income was -19,582,000 GBP.
Operating cash flow was 1,727,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 244,000 GBP
- Operating income
- -22,734,000 GBP
- Net income
- -19,582,000 GBP
- Operating cash flow
- 1,727,000 GBP